10.24376/rd.sgul.5831706.v1
Corinne Merle
Corinne
Merle
RAFA Trial Results: High Dose Rifampicin Tuberculosis treatment regimen to reduce 12 month mortality of TB/HIV co-infected patients
St George's, University of London
2018
TB
INTERTB
Tuberculosis
Clinical Trials
Rifampicin
Treatment
Results
Global Health
HIV
Immunology
Infectious Diseases
Medicine
Pharmacology
2018-02-05 17:02:04
Presentation
https://sgul.figshare.com/articles/presentation/RAFA_Trial_Results_High_Dose_Rifampicin_Tuberculosis_treatment_regimen_to_reduce_12_month_mortality_of_TB_HIV_co-infected_patients/5831706
RAFA Trial Results: High Dose Rifampicin Tuberculosis treatment regimen to reduce 12 month mortality of TB/HIV co-infected patients - Corinne Merle.<br><br>This presentation was delivered at the 2017 INTERTB symposium, held at
St George’s, University of London. The full collection of outputs from
the meeting can be accessed from the link referenced below.